Jane Street’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.5K | Sell |
10,118
-247,685
| -96% | -$991K | ﹤0.01% | 5128 |
|
|
2025
Q1 | $820K | Buy |
257,803
+142,851
| +124% | +$454K | ﹤0.01% | 3302 |
|
|
2024
Q4 | $615K | Buy |
114,952
+64,731
| +129% | +$346K | ﹤0.01% | 3641 |
|
|
2024
Q3 | $265K | Buy |
+50,221
| New | +$265K | ﹤0.01% | 4977 |
|
|
2024
Q1 | – | Sell |
-23,095
| Closed | -$40.6K | – | 5835 |
|
|
2023
Q4 | $40.6K | Buy |
+23,095
| New | +$40.6K | ﹤0.01% | 5432 |
|
|
2023
Q3 | – | Sell |
-35,118
| Closed | -$80.4K | – | 5217 |
|
|
2023
Q2 | $80.4K | Buy |
+35,118
| New | +$80.4K | ﹤0.01% | 4858 |
|
|
2022
Q4 | – | Sell |
-20,775
| Closed | -$17K | – | 5605 |
|
|
2022
Q3 | $17K | Buy |
+20,775
| New | +$17K | ﹤0.01% | 5345 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5713 |
|
|
2021
Q4 | – | Sell |
-173,937
| Closed | -$842K | – | 5393 |
|
|
2021
Q3 | $842K | Buy |
+173,937
| New | +$842K | ﹤0.01% | 2852 |
|